LXLan Xiao

Lan Xiao

*This is an algorithmically generated author record based on publicly available information.

Lan Xiao has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Short‐term weight loss patterns, baseline predictors, and longer‐term follow‐up within a randomized controlled trial

    by Veronica Yank, Lan Xiao, Sandra R. Wilson, Randall S. Stafford, Lisa Goldman Rosas, Jun Ma

    Objective To examine weight loss patterns and predictors among participants in a primary care‐based translation study of the Diabetes Prevention Program lifestyle intervention. Design and Methods Cluster analysis identified short‐term (12‐week) weight loss patterns among 72 intervention participants. Analysis of variance assessed cluster differences in weight loss maintenance at 15‐month follow‐up. Discriminant analysis identified baseline characteristics that best differentiated between clusters. Results Participants had baseline mean (SD) age of 55.0 (10.8) years and BMI of 31.9 (5.2) kg/m2. Cluster analysis identified three short‐term weight loss patterns: modest (n = 15; 21%), moderate‐and‐steady (n = 43; 60%), and substantial‐and‐early (n = 14; 19%). Only participants with the latter two patterns achieved clinically significant (≥5%) short‐term weight loss and maintained it at 15 months. On discriminant analysis, the modest cluster was most differentiated from other clusters by high friend encouragement for dietary change, high obesity‐related problems, and low physical well‐being. The moderate‐and‐steady cluster was differentiated by lower physical activity, family encouragement, and depression symptoms. Conclusion Results provided insight into the heterogeneity of response to an effective lifestyle intervention by identifying short‐term weight loss patterns and their baseline predictors and relationship to 15‐month success. If replicated, results may help tailor strategies for participant subgroups in weight loss programs.


  • Open Access

    Translating the Diabetes Prevention Program Lifestyle Intervention for Weight Loss Into Primary Care

    by Jun Ma, Veronica Yank, Lan Xiao, Philip W. Lavori, Sandra R. Wilson, Lisa G. Rosas, Randall S. Stafford

    An estimated 69% of US adults are overweight or obese,1 and those with modifiable cardiometabolic risk factors are a critical target group for intervention.2,3 Lifestyle modification focused on modest (5%-10%) weight loss and moderate-intensity physical activity can significantly reduce the incidence of type 2 diabetes mellitus (DM) (as much as 58% as shown in the Diabetes Prevention Program [DPP]) and cardiometabolic risk factors in high-risk individuals,4-6 with benefits sustained for at least 10 years.7 Evidence-based guidelines therefore recommend effective lifestyle intervention for weight management and disease prevention.8,9


  • Open Access

    The Breathe Easier through Weight Loss Lifestyle (BE WELL) Intervention: A randomized controlled trial

    by Jun Ma, Peg Strub, Carlos A CamargoJr, Lan Xiao, Estela Ayala, Christopher D Gardner, A Sonia Buist, William L Haskell, Phillip W Lavori, Sandra R Wilson

    Obesity and asthma have reached epidemic proportions in the US. Their concurrent rise over the last 30 years suggests that they may be connected. Numerous observational studies support a temporally-correct, dose-response relationship between body mass index (BMI) and incident asthma. Weight loss, either induced by surgery or caloric restriction, has been reported to improve asthma symptoms and lung function. Due to methodological shortcomings of previous studies, however, well-controlled trials are needed to investigate the efficacy of weight loss strategies to improve asthma control in obese individuals. BE WELL is a 2-arm parallel randomized clinical trial (RCT) of the efficacy of an evidence-based, comprehensive, behavioral weight loss intervention, focusing on diet, physical activity, and behavioral therapy, as adjunct therapy to usual care in the management of asthma in obese adults. Trial participants (n = 324) are patients aged 18 to 70 years who have suboptimally controlled, persistent asthma, BMI between 30.0 and 44.9 kg/m2, and who do not have serious comorbidities (e.g., diabetes, heart disease, stroke). The 12-month weight loss intervention to be studied is based on the principles of the highly successful Diabetes Prevention Program lifestyle intervention. Intervention participants will attend 13 weekly group sessions over a four-month period, followed by two monthly individual sessions, and will then receive individualized counseling primarily by phone, at least bi-monthly, for the remainder of the intervention. Follow-up assessment will occur at six and 12 months. The primary outcome variable is the overall score on the Juniper Asthma Control Questionnaire measured at 12 months. Secondary outcomes include lung function, asthma-specific and general quality of life, asthma medication use, asthma-related and total health care utilization. Potential mediators (e.g., weight loss and change in physical activity level and nutrient intake) and moderators (e.g., socio-demographic characteristics and comorbidities) of the intervention effects also will be examined. This RCT holds considerable potential for illuminating the nature of the obesity-asthma relationship and advancing current guidelines for treating obese adults with asthma, which may lead to reduced morbidity and mortality related to the comorbidity of the two disorders. NCT00901095


  • Open Access

    Evaluation of lifestyle interventions to treat elevated cardiometabolic risk in primary care (E-LITE): a randomized controlled trial

    by Jun Ma, Abby C King, Sandra R Wilson, Lan Xiao, Randall S Stafford

    Efficacy research has shown that intensive individual lifestyle intervention lowers the risk for developing type 2 diabetes mellitus and the metabolic syndrome. Translational research is needed to test real-world models of lifestyle interventions in primary care settings.